HomeEQL • STO
add
EQL Pharma AB
Previous close
kr 48.55
Day range
kr 48.40 - kr 49.80
Year range
kr 46.55 - kr 108.80
Market cap
1.46B SEK
Avg Volume
40.06K
P/E ratio
49.22
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 86.38M | 1.33% |
Operating expense | 28.82M | 41.28% |
Net income | -3.36M | -135.18% |
Net profit margin | -3.89 | -134.67% |
Earnings per share | -0.11 | — |
EBITDA | 5.67M | -64.29% |
Effective tax rate | 20.57% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 78.26M | 561.60% |
Total assets | 825.18M | 94.94% |
Total liabilities | 565.18M | 150.74% |
Total equity | 260.00M | — |
Shares outstanding | 29.53M | — |
Price to book | 5.52 | — |
Return on assets | 1.11% | — |
Return on capital | 1.29% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -3.36M | -135.18% |
Cash from operations | 1.33M | -6.39% |
Cash from investing | -9.18M | 16.00% |
Cash from financing | 30.00M | 276.78% |
Net change in cash | 22.16M | 1,536.77% |
Free cash flow | -11.62M | 32.01% |
About
Founded
2006
Website
Employees
22
